{"id":195356,"date":"2026-08-11T09:38:16","date_gmt":"2026-08-11T04:08:16","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=195356"},"modified":"2026-08-11T09:38:16","modified_gmt":"2026-08-11T04:08:16","slug":"thyrocare-technologies-ltd-share-price-52-week-high-2026-08-11","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/thyrocare-technologies-ltd-share-price-52-week-high-2026-08-11\/","title":{"rendered":"Thyrocare Technologies Ltd. (THYROCARE) Share Price Hits Fresh 52-Week High"},"content":{"rendered":"<style id=\"univest-disable-toc\">#ez-toc-container,.ez-toc-container,.lwptoc,.toc_container,.wp-block-rank-math-toc-block{display:none!important}<\/style>\n<p style=\"margin-top:0!important;margin-bottom:0!important;\"><a href=\"https:\/\/univest.in\/stocks\/thyrocare\/thyrocare-technologies-ltd-share-price-today\">Thyrocare Technologies Ltd.<\/a> Share Price stood at Rs 627.5, up 0.95% today, after hitting a fresh 52-week high of Rs 629.85. Market capitalisation stood at Rs 9,606.42 crore.<\/p>\n<p style=\"margin-top:0!important;\">Thyrocare Technologies Ltd. Share Price was at Rs 627.5 on 11 August 2026, up Rs 5.9 or 0.95% from the previous close of Rs 621.6, after the stock touched a fresh 52-week high of Rs 629.85. The company\u2019s market capitalisation stood at Rs 9,606.42 crore, placing it among the larger names in the supplied Healthcare stock set. For investors tracking Thyrocare Technologies Ltd. Share Price Today, the verified data confirms a new one-year high, even though it does not establish any company-specific catalyst behind the move.<\/p>\n<p>That matters because a 52-week high often puts a stock on screens such as Stocks in News, 52 Week High Stocks and Market Movers across the Indian Stock Market. In this case, the day\u2019s trading band remained narrow, with the stock opening at Rs 629.85, also the intraday high, and dipping to Rs 625.9. Volume was 908 shares with turnover of Rs 0.06 crore at the time of the event, showing the move was recorded early in the session. For readers following Thyrocare Technologies Ltd. Stock News, the immediate takeaway is straightforward: the price event is verified, the valuation metrics are elevated versus several sector benchmarks, and the next step is to judge whether the company\u2019s profitability profile supports continued investor attention. Univest tracks that full picture through price action, stock analysis and sector context.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Thyrocare_Technologies_Ltd_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Thyrocare Technologies Ltd. Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 627.5<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 621.6<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Change<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">+Rs 5.9 (+0.95%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 629.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Fresh 52-Week High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 629.85<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Day Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 625.9<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Volume<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">908<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 0.06 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 9,606.42 crore<\/td>\n<\/tr>\n<\/table>\n<p>Thyrocare Technologies Ltd. (THYROCARE) traded at Rs 627.5. versus the previous close of Rs 621.6, a rise of 0.95%. The stock opened at Rs 629.85, reached Rs 629.85, touched Rs 625.9. Reported volume was 908.<\/p>\n<p>Thyrocare Technologies Ltd. Share Price Today reflects a confirmed breakout to a fresh yearly high, with the stock rising 0.95% over the previous close and touching Rs 629.85 during the session. The price move is modest in percentage terms, but the one-year high puts the stock firmly on the market\u2019s watchlist.<\/p>\n<p>From the supplied trading data, Thyrocare Technologies Ltd. Share Price opened at Rs 629.85, which was also the day\u2019s high, before easing to Rs 627.5. The session low was Rs 625.9, still above the previous close of Rs 621.6. That sequence suggests the stock moved into fresh 52-week peak territory early in the day and then held most of the gain rather than giving back the entire breakout.<\/p>\n<p>The absolute day change was Rs 5.9, equivalent to 0.95%. Current volume stood at 908 shares, while turnover was Rs 0.06 crore when the event was captured at 11 August 2026 at 9:16:48 AM IST. Because the event was detected early in the trading session, the price action should be read as an intraday Share Price Update rather than a full-day conclusion. Still, a fresh one-year high is enough to place Thyrocare Technologies Ltd. Share Price in current Stock Market Today conversations, especially when a stock is already trading near the top of its yearly range.<\/p>\n<p>For market participants scanning Thyrocare Technologies Ltd. NSE and Thyrocare Technologies Ltd. BSE related searches, the verified data establishes what happened: the stock made a new 52-week high at Rs 629.85 and continued to trade close to that level. The supplied dataset does not identify a specific corporate trigger, so the focus shifts naturally from intraday price action to valuation and financial quality.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Thyrocare_Technologies_Ltd_THYROCARE_Fundamental_Analysis\"><\/span><strong>Thyrocare Technologies Ltd. (THYROCARE) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 9,606.42 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">40.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<\/table>\n<p>Thyrocare Technologies Ltd. was valued at a P\/E ratio of 40.09x, a P\/B ratio of 9.77x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.<\/p>\n<p>Profitability and capital efficiency were represented by ROE of 28.21% and ROCE of 26.35%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same sector<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">40.09x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.84x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">76.55x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0x to 3,396.3x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">9.77x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">1.93x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">28.21%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.77%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">26.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 9,606.42 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 142.3 crore<\/td>\n<\/tr>\n<\/table>\n<p>Thyrocare Technologies Ltd. (THYROCARE) is classified under sector: Healthcare.<\/p>\n<p>Thyrocare Technologies Ltd. (THYROCARE) has a P\/E ratio of 40.09x, which is above the benchmark median of 20.84x, a difference of +92.37%. P\/E is a valuation multiple and is not, by itself, a buy or sell signal.<\/p>\n<p>Thyrocare Technologies Ltd. (THYROCARE) has a ROE of 28.21%, which is above the benchmark median of 10.77%, a difference of +161.93%. Thyrocare Technologies Ltd. (THYROCARE) has a ROCE of 26.35%, which is above the benchmark median of 13.35%, a difference of +97.38%.<\/p>\n<p>Track stocks reaching yearly peaks through the <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>. The peer table below provides the company-level comparison.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/kpl\/kwality-pharmaceuticals-ltd-share-price-today\"><strong>Kwality Pharmaceuticals Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">KPL<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,707.2<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">40.09<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">9.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">28.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/beta\/beta-drugs-ltd-share-price-today\"><strong>Beta Drugs Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">BETA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,631.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">66.92<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">10.59<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">18.65<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">22.17<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/dragarwq\/dr-agarwals-eye-hospital-ltd-share-price-today\"><strong>Dr Agarwals Eye Hospital Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DRAGARWQ<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,601.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">34.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">7.04<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">-2.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.92<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/saiparent\/sai-parenteral-s-ltd-share-price-today\"><strong>Sai Parenteral&#39;s Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SAIPARENT<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,513.58<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">181.97<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.36<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">13.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">12.97<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/nglfine\/ngl-fine-chem-ltd-share-price-today\"><strong>NGL Fine-Chem Ltd.<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">NGLFINE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,118.6<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">44.48<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">6.5<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">27.9<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.91<\/td>\n<\/tr>\n<\/table>\n<p>Thyrocare Technologies Ltd. (THYROCARE) has a P\/E ratio of 40.09x compared with the displayed peer median of 44.48x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 28.21% compares with a peer median of 18.65% across the companies shown in the table. ROCE stood at 26.35% versus the displayed peer median of 22.17%, providing a capital-efficiency comparison. Thyrocare Technologies Ltd. (THYROCARE) has a market capitalisation of Rs 9,606.42 crore. Among the 5 peers shown, 0 have a larger market capitalisation.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Thyrocare_Technologies_Ltd\"><\/span><strong>Why Investors Are Watching Thyrocare Technologies Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This stock is being watched because the data combines a fresh 52-week high with premium valuation and above-benchmark profitability. For anyone following Thyrocare Technologies Ltd. Share Price Live or Thyrocare Technologies Ltd. News Today, the attraction lies in that combination rather than in any verified company-specific trigger.<\/p>\n<ul>\n<li><strong>Fresh price event:<\/strong> The stock touched a new 52-week high of Rs 629.85 and was trading at Rs 627.5, up 0.95% from Rs 621.6.<\/li>\n<li><strong>Intraday resilience:<\/strong> The day\u2019s low of Rs 625.9 stayed above the previous close, while the stock remained close to the day\u2019s high after opening at Rs 629.85.<\/li>\n<li><strong>Profitability profile:<\/strong> ROE of 28.21% and ROCE of 26.35% are both above the supplied Healthcare sector median and average.<\/li>\n<li><strong>Valuation context:<\/strong> P\/E of 40.09 is above the sector median of 20.84, and P\/B of 9.77 is far above the sector median of 1.93.<\/li>\n<li><strong>Scale:<\/strong> Market capitalisation of Rs 9,606.42 crore is far above the benchmark median of Rs 142.3 crore and average of Rs 472.15 crore.<\/li>\n<li><strong>Peer relevance:<\/strong> The company\u2019s market value and returns compare strongly with the selected peer group, keeping Thyrocare Technologies Ltd. Stock Performance in focus.<\/li>\n<\/ul>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"About_Thyrocare_Technologies_Ltd\"><\/span><strong>About Thyrocare Technologies Ltd.<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>This section uses only the supplied company context. Thyrocare Technologies Ltd. is identified in the dataset as a listed company tracked under the Healthcare sector. The stock trades under the symbol THYROCARE, and current investor attention is centred on its fresh one-year high, valuation multiples and profitability profile relative to the same-sector benchmark and listed peers.<\/p>\n<p>Because the supplied article data does not include business segments, revenue mix, products or a detailed company description, the clearest factual takeaway is its sector positioning. Within Healthcare, Thyrocare Technologies Ltd. is being monitored as a relatively large company by market capitalisation, with a P\/E of 40.09, P\/B of 9.77, ROE of 28.21% and ROCE of 26.35%. Those figures help explain why Thyrocare Technologies Ltd. Company News and Thyrocare Technologies Ltd. Share Price Update searches may rise when the stock appears among yearly high counters. In practical terms, investors are tracking how this Healthcare name is being valued against its sector and peer set after the move to a fresh 52-week peak.<\/p>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Track_Thyrocare_Technologies_Ltd_Share_Price_on_Univest\"><\/span><strong>Track Thyrocare Technologies Ltd. Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use <a href=\"https:\/\/univest.in\/stocks\/thyrocare\/thyrocare-technologies-ltd-share-price-today\">Thyrocare Technologies Ltd. (THYROCARE) live share-price page<\/a>, <a href=\"https:\/\/univest.in\/screeners\/52-week-high\">Univest 52-week-high screener<\/a>, <a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, yearly-high lists and related market analysis.<\/p>\n<p>Univest helps users follow Thyrocare Technologies Ltd. Share Price through live price tracking, 52-week levels, stock analysis, valuation ratios, peer comparison and sector context in one place. For investors monitoring Thyrocare Technologies Ltd. Share Price Today, that means the ability to watch the latest price, market cap, P\/E, P\/B, ROE, ROCE and broader Healthcare benchmarks together rather than in isolation.<\/p>\n<p>Users can also use Univest to monitor Thyrocare Technologies Ltd. Stock News, Thyrocare Technologies Ltd. Shareholding Pattern when updated, 52 Week High movements, market insights and related Stock Updates across the Indian Stock Market. As this event shows, a fresh 52-week high can be more meaningful when read alongside financial ratios and peer positioning. That is where Univest adds value: it helps turn a simple price alert into a fuller market context without turning it into a recommendation.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong> Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2 class=\"ez-toc-exclude\"><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_latest_Thyrocare_Technologies_Ltd_Share_Price_Today\"><\/span><strong>What is the latest Thyrocare Technologies Ltd. Share Price Today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Thyrocare Technologies Ltd. Share Price Today was Rs 627.5 at the time of the event. The stock was up Rs 5.9 or 0.95% from the previous close of Rs 621.6 on 11 August 2026.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_the_fresh_52-week_high_for_Thyrocare_Technologies_Ltd\"><\/span><strong>What was the fresh 52-week high for Thyrocare Technologies Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Thyrocare Technologies Ltd. hit a fresh 52-week high of Rs 629.85. The stock also opened at Rs 629.85, and it later traded at Rs 627.5 while staying close to that one-year peak intraday.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Why_is_Thyrocare_Technologies_Ltd_Share_Price_rising_today\"><\/span><strong>Why is Thyrocare Technologies Ltd. Share Price rising today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The supplied data confirms that Thyrocare Technologies Ltd. Share Price rose 0.95% and touched a fresh 52-week high. However, the verified dataset does not establish any company-specific catalyst behind the move at the recorded time.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_does_todays_price_action_show_for_THYROCARE\"><\/span><strong>What does today\u2019s price action show for THYROCARE?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> THYROCARE opened at Rs 629.85, touched the same level as the day\u2019s high, and traded down to a low of Rs 625.9. Even so, it remained above the previous close of Rs 621.6.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_the_market_capitalisation_of_Thyrocare_Technologies_Ltd\"><\/span><strong>What is the market capitalisation of Thyrocare Technologies Ltd.?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Thyrocare Technologies Ltd. had a market capitalisation of Rs 9,606.42 crore in the supplied data. That is far above the Healthcare sector benchmark median of Rs 142.3 crore and average of Rs 472.15 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Is_Thyrocare_Technologies_Ltd_expensive_compared_with_the_Healthcare_sector\"><\/span><strong>Is Thyrocare Technologies Ltd. expensive compared with the Healthcare sector?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> On supplied sector data, Thyrocare Technologies Ltd. trades at a P\/E of 40.09 versus the Healthcare median of 20.84. Its P\/B of 9.77 is also above the sector median of 1.93 and average of 2.64.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_profitable_is_Thyrocare_Technologies_Ltd_on_the_supplied_numbers\"><\/span><strong>How profitable is Thyrocare Technologies Ltd. on the supplied numbers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> The company\u2019s ROE is 28.21% and ROCE is 26.35% in the supplied dataset. Both are above the Healthcare sector median levels of 10.77% and 13.35%, respectively, giving useful context to investor attention.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Thyrocare_Technologies_Ltd_compare_with_selected_peers\"><\/span><strong>How does Thyrocare Technologies Ltd. compare with selected peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Thyrocare Technologies Ltd. has a market cap of Rs 9,606.42 crore, above the supplied peers. Its P\/E of 40.09 is below Beta Drugs and Sai Parenteral&#39;s, but above Dr Agarwals Eye Hospital.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_sector_does_Thyrocare_Technologies_Ltd_belong_to\"><\/span><strong>What sector does Thyrocare Technologies Ltd. belong to?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Thyrocare Technologies Ltd. is classified under the Healthcare sector in the supplied dataset. The same-sector benchmark used here covers 197 companies, which provides the reference base for valuation and profitability comparison.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"Where_can_investors_track_Thyrocare_Technologies_Ltd_Share_Price_and_stock_data\"><\/span><strong>Where can investors track Thyrocare Technologies Ltd. Share Price and stock data?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong> Investors can track Thyrocare Technologies Ltd. Share Price on Univest for live price moves, 52-week levels, valuation ratios, sector context and peer comparison. That helps place a fresh one-year high in broader analytical context.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Thyrocare Technologies Ltd. Share Price hits a new 52-week high at Rs 627.5. marking a 0.95% rise today. Market cap stands at Rs 9,606.42 crore.<\/p>\n","protected":false},"author":29,"featured_media":195355,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-195356","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["195355"],"rank_math_title":["Thyrocare Technologies Ltd. Share Price at 52-Week High"],"rank_math_description":["Thyrocare Technologies Ltd. Share Price hit a fresh 52-week high at Rs 629.85. Read price action, valuation, sector benchmarks and peer analysis."],"rank_math_focus_keyword":["Thyrocare Technologies Ltd. Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/08\/Thyrocare_Technologies_Ltd_THYROCARE_Share_Price_Hits_Fresh_52_Week_High_bullish.png","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195356","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=195356"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195356\/revisions"}],"predecessor-version":[{"id":195357,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/195356\/revisions\/195357"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/195355"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=195356"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=195356"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=195356"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}